Skip to content

A Treatment Study Comparing Two Non-Drug, Self-Help Treatment of Chronic Insomnia.

Computerized Self-Help Treatment for Primary Insomnia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00310284
Enrollment
200
Registered
2006-04-03
Start date
2006-01-31
Completion date
Unknown
Last updated
2006-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Keywords

Insomnia, Sleep

Brief summary

The purpose of this study is to determine whether a handheld computer is superior to a self-help manual for the treatment of chronic primary insomnia.

Detailed description

Chronic primary insomnia is a highly prevalent condition, affecting up to 15% of the population. The condition is associated with daytime fatigue, lack of concentration, and decreased quality of life. Most people with chronic primary insomnia go untreated, because of a desire to avoid medication or lack of access to quality non-drug treatments. Therefore, an affordable, easy to use, and effective computer to help assess and treat insomnia symptoms could bring treatment to this population. Comparison: We are comparing a new handheld computer that uses cognitive-behavioral treatment principles to a popular self-help manual for the treatment of primary insomnia symptoms.

Interventions

BEHAVIORALComputerized delivery of cognitive-behavioral treatment of insomnia
BEHAVIORALSelf-help manual to improve insomnia symptoms

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
PICS, Inc.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* sleep less than 6.5 hours per night * at least 30 minutes of sleep onset latency or wakefulness after sleep onset * symptoms present for at least 6 months * must have insomnia symptoms at least 3 days per week

Exclusion criteria

* Body Mass Index greater than 32 * Presence of anxiety disorder * Secondary forms of insomnia * Presence of a substance use disorder * Concurrent treatment for another mental disorder * History of other sleep disorders, including: apnea, restless legs, periodic limb movement disorder, or narcolepsy

Design outcomes

Primary

MeasureTime frame
Changes in symptom severity as measured by the Multi-dimensional Fatigue Inventory
Changes in sleep parameters via self-reported sleep diary
Changes in symptom severity as measured by Insomnia Severity Index
Changes in symptom severity as measured by Pittsburgh Sleep Quality Index
Changes in sleep parameters via polysomnography

Secondary

MeasureTime frame
Changes in quality of life as measured by a qualitative instrument
Usability of the device as measured by a qualitative questionnaire
Changes in depression symptoms as measured by Beck Depression Inventory II

Countries

United States

Contacts

Primary ContactAnahi Collado-Rodriguez, B.S.
acollado@lifesign.com703-766-2849

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026